spin

Date

4 - 5 November

Location

ALOFT KUALA LUMPUR SENTRAL HOTEL, KUALA LUMPUR, MALAYSIA

Conference Schedule / draft

Attendee Registration

Welcome Remarks by Advisory Board Co-Chairs

Coffee / Tea Break

Session 1 : Introducing Regulatory Reliance

Session Chair: Greg Perry, Assistant Director General, IFPMA

Lunch & Learn Session (Optional)

Regulation of Cell & Gene Therapies- An Industry Perspective
  • Brief introduction to Cell and Gene Therapies
  • Unique challenges regarding R&D and Production
  • Current regulatory landscape and barrier
  • Interactive discussion and Audience Q&A

Special Session & Conference Highlight

The Role of ICMRA in Regulatory Strengthening and Convergence & Asia Training Center for Pharmaceutical and Medical Devices Regulatory Affairs (PMDA-ATC)

Session 2: Fostering Systems Strengthening and RegulatoryConvergence

Session Chairs: Yasuhiro Fujiwara, PMDA& David Jefferys, IFPMA

Coffee / Tea Break

Session 3: Focus on Pharmacovigilance

Chair: Raj Long, Deputy Director, Integrated Development Global Health,Bill & Melinda Gates Foundation

Day 1 Wrap-up

Networking Reception

Location : Aloft Sentral Hotel Ballroom

Attendee Registration

Welcome Remarks by Advisory Board Co-Chairs

Coffee / Tea Break

Session 1 : Introducing Regulatory Reliance

Session Chair: Greg Perry, Assistant Director General, IFPMA

Lunch & Learn Session (Optional)

Regulation of Cell & Gene Therapies- An Industry Perspective
  • Brief introduction to Cell and Gene Therapies
  • Unique challenges regarding R&D and Production
  • Current regulatory landscape and barrier
  • Interactive discussion and Audience Q&A

Special Session & Conference Highlight

The Role of ICMRA in Regulatory Strengthening and Convergence & Asia Training Center for Pharmaceutical and Medical Devices Regulatory Affairs (PMDA-ATC)

Session 2: Fostering Systems Strengthening and RegulatoryConvergence

Session Chairs: Yasuhiro Fujiwara, PMDA& David Jefferys, IFPMA

Session 3: Focus on Pharmacovigilance

Chair: Raj Long, Deputy Director, Integrated Development Global Health,Bill & Melinda Gates Foundation

Coffee / Tea Break

Day 1 Wrap-up

Networking Reception

Location : Aloft Sentral Hotel Ballroom

Session 4: ICH in Asia

Session Chair: Sharon Olmstead, IFPMA

Coffee / Tea Break

Session 5: Supporting Regulatory Convergence in Asia

Lunch & Learn Session (Optional)

WHO post approval change guidance and ICH Q12 Principles - an Industry perspective

Session 6: Supporting Regulatory Convergence for Vaccines in Asia

Session Chair: Mic McGoldrick, IFPMA VSRWG

Session 7: Innovative Solutions for a Safer Supply Chain

Session Chair: Greg Perry, IFPMA

Conference Wrap-up and Interactive Discussion on 10th ARC Recommendations & Outcomes

Closing Remarks

IFPMA / PhAMA

Session 4: ICH in Asia

Session Chair: Sharon Olmstead, IFPMA

Coffee / Tea Break

Session 5: Supporting Regulatory Convergence in Asia

Lunch & Learn Session (Optional)

WHO post approval change guidance and ICH Q12 Principles - an Industry perspective

Session 6: Supporting Regulatory Convergence for Vaccines in Asia

Session Chair: Mic McGoldrick, IFPMA VSRWG

Session 7: Innovative Solutions for a Safer Supply Chain

Session Chair: Greg Perry, IFPMA

Conference Wrap-up and Interactive Discussion on 10th ARC Recommendations & Outcomes

Closing Remarks

IFPMA / PhAMA

Program Committee

Manabu Yanagisawa

Director Global Scientific and Regulatory Affairs Japan Pharmaceutical Manufacturers Association (JPMA)

Sannie Chong

Asia Pacific Technical Regulatory Policy Roche Singapore Technical Operations

Mic McGoldrick

Global CMC Policy Merck Sharp & Dohme Corp.

Janice Tan

Head of Regulatory Affairs Novartis Malaysia

Jayanthi Boobalan

Head of Regional Regulatory Hub, Global Regulatory Affairs International, Asia Pfizer Inc.

Alice (Seat Mee) CHEE

Regulatory Consultant Pharmaceutical Association of Malaysia (PhAMA)

Janis Bernat

Director, Biotherapeutics & Scientific Affairs IFPMA

Sergio Cavalheiro Filho

Assistant Manager, Regulatory Affairs, IFPMA

Mümün Gencoglu

Manager, Regulatory Affairs IFPMA

Sarah Adam

Senior Manager for Regulatory and Scientific Affairs IFPMA

Advisory Board

Director, Biotherapeutics & Scientific Affairs IFPMA

Regulatory Science Committee Chair IFPMA

Executive Director CIRS

Secretary General CIOMS

Executive Director, Duke-NUS Senior Advisor, MOH  

Board Member IAPO (International Alliance of Patients Organizations)

Adjunct Professor & ICMRA Vice Chair TGA / ICMRA

Director NPRA (Malaysia)

Office Director of Office of International Cooperation PMDA

Group Lead Regulatory Networks and Harmonization [RNH] Regulatory Systems Strengthening [RSS] WHO

Venue

Hotel and Travels

Travel & Visa Information :

UPDATE: Participants are advised to carefully read WHO’s advice for international travel and trade in relation to the outbreak of pneumonia caused by a new coronavirus in China before making any travel arrangements. Please monitor the situation closely.

Most nationalities can enter in Malaysia without a visa for stays of up to a month.

Before traveling, make sure you are aware of what are the current requirements for your country and what type of visa, if any, you will need.

Invitation letters can be sent upon request. Should you need any additional VISA information, you can contact events@phama.org.my

 

Hotels:

kulmd-exterior-0326-hor-clsc

Le Méridien Kuala Lumpur
2 Jalan Stesen Sentral, Kuala Lumpur Sentral
Kuala Lumpur, 50470 Malaysia

hilton

Hilton Kuala Lumpur
3, Jalan Stesen Sentral
Kuala Lumpur, 50470 Malaysia

360927a_hb_a_002

Ascott Sentral Kuala Lumpur
No. 211, Jalan Tun Sambanthan
Kuala Lumpur, 50470 Malaysia

219877405

Alila Bangsar Kuala Lumpur
 58, Jalan Ang Seng, Brickfields
50470 Kuala Lumpur

24825_394850332560_7287495_n-848x494

Hotel Sentral Kuala Lumpur
No 30, Jalan Thambypilla Brickfields
50470 Kuala Lumpur